United Therapeutics receives subpoena from Office of Inspector General United Therapeutics announced that it has received a subpoena from the Office of the Inspector General of the Department of Health and Human Services reflecting an investigation by the United States Department of Justice, principally represented by the United States Attorney's Office in Baltimore. The subpoena requests documents regarding Remodulin Injection, Tyvaso Inhalation Solution and Adcirca Tablets, including the company's marketing practices relating to these products. The company intends to cooperate with the investigation.
News For UTHR From The Last 14 Days
Check below for free stories on UTHR the last two weeks.